Showing results (1-10 of 92) with videos related to
Sort By:
Pageof 10
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 15, 1975
Influence of L-3-methoxytyrosine on monoamine synthesis in rat brainW KehrArzneimittel-Forschung|January 1, 1976
[Interactions of dopamine receptor agonists and antagonists with regard to dopamine synthesis and metabolism]W KehrArchiv Der Pharmazie|April 1, 1995
Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVI: Antiplatelet and antithrombotic effects of the oligoamine RE 1492 in combination with standard and future antithrombotic drugsK Rehse, T CiborskiArchiv Der Pharmazie|January 1, 1995
New no-donors with antithrombotic and vasodilating activities, X: Antiplatelet and antithrombotic effects of 3-methylsydnone-5-nitrosimine (RE 2047) in combination with ASA, pentoxifylline, and ticlopidineK Rehse, T CiborskiArchiv Der Pharmazie|May 1, 1993
Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXI: 4,4'-Alkylene-bis-sydnone iminesK Rehse, A MartensArchiv Der Pharmazie|April 1, 1993
Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XX: 4,4',4''-(1,3,5)-benzene-tris-sydnone iminesK Rehse, A MartensArchiv Der Pharmazie|February 1, 1995
New NO-donors with antithrombotic and vasodilating activities, XII: Mesoionic oxatriazoles and related noncyclic nitrosohydrazine derivativesK Rehse, P KönigArchiv Der Pharmazie|December 9, 1998
New NO donors with antithrombotic and vasodilating activities, Part 24. Hydrazine derivativesK Rehse, T ShahrouriArchiv Der Pharmazie|April 29, 1998
New NO-donors with antithrombotic and vasodilating activities, Part 20. Azodioxides activated by electron acceptors in geminal or vicinal positionK Rehse, M HerpelPharmacopsychiatry|March 1, 1985
Receptor-mediated regulation of 5-hydroxytryptamine metabolism: current knowledge and open questionsW KehrPageof 10